SEI Investments’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.25M Buy
74,223
+35,010
+89% +$1.19M ﹤0.01% 1901
2026
Q2
$1.25M Sell
39,213
-22,047
-36% -$652K ﹤0.01% 2191
2026
Q1
$1.85M Buy
61,260
+10,923
+22% +$353K ﹤0.01% 2049
2025
Q4
$1.75M Buy
50,337
+15,352
+44% +$542K ﹤0.01% 1920
2025
Q3
$1.27M Buy
34,985
+3,651
+12% +$124K ﹤0.01% 1882
2025
Q2
$983K Buy
31,334
+20,598
+192% +$640K ﹤0.01% 1936
2025
Q1
$319K Buy
+10,736
New +$322K ﹤0.01% 2317
2024
Q2
– Sell
-5,807
Closed -$377K – 2684
2024
Q1
$377K Buy
5,807
+107
+2% +$7.34K ﹤0.01% 2218
2023
Q4
$389K Sell
5,700
-22,507
-80% -$1.17M ﹤0.01% 2212
2023
Q3
$1.46M Buy
28,207
+620
+2% +$36.7K ﹤0.01% 1738
2023
Q2
$1.65M Sell
27,587
-14,267
-34% -$814K ﹤0.01% 1703
2023
Q1
$2.07M Buy
41,854
+29,390
+236% +$1.65M ﹤0.01% 1601
2022
Q4
$711K Sell
12,464
-16,259
-57% -$915K ﹤0.01% 1883
2022
Q3
$1.35M Buy
+28,723
New +$1.37M ﹤0.01% 1698

Other funds holding IMCR

SEI Investments's IMCR Position: Q3 2026 in Review

SEI Investments increased its Immunocore (IMCR) stake by 89% in Q3 2026, buying an estimated $1.19M and bringing the position to 74,223 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

SEI Investments first reported a position in IMCR in Q3 2022 and has held it in 14 quarters since. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • SEI Investments held 74,223 shares of Immunocore worth $2.25M as of Q3 2026.
  • SEI Investments bought 35,010 Immunocore shares in Q3 2026, an estimated $1.19M.
  • Immunocore made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #1901 holding.
  • SEI Investments first reported a position in Immunocore in Q3 2022 and has held it in 14 quarters since.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.